Ipilimumab for Head and Neck Cancer Patients
Clinical trial NCT02812524 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02812524
- Sponsor
- Providence Health & Services
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-18
- Primary completion
- 2019-09-21
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.